TrialJournal of ovarian research2015

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study.

Mojca Jensterle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.